Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $212.87 (market cap $39.15B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 22.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is more actively traded (9,289,619 versus 2,708,429). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 110 Days on average.
| NUVB | TTWO | |
|---|---|---|
Market Cap | $1.74B | $39.15B |
Volume | 9,289,619 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $9.54 | $262.29 |
52-Week Low | $3.41 | $189.69 |
Typical Hold Time | 0 Days | 110 Days |
Enterprise Value | $1.33B | $40.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Take-Two Interactive trades at $204.01, up 0.73% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces fundamental challenges with a net loss of -$4.48 billion in 2025 and negative profit margins, though revenue grew to $5.63 billion. Recent news highlights GTA VI's confirmed November 2026 launch date as a potential catalyst, while institutional buying and strong analyst support (79% buy ratings) suggest long-term confidence despite current profitability issues.
The outlook hinges on GTA VI's successful execution, with analyst consensus target at $292.30 representing 43% upside. Key risks include persistent negative cash flow from operations, high debt levels, and execution challenges in the competitive gaming sector. The stock offers substantial potential upside if management can translate strong franchises into sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
